Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Michael, Gill"'
Publikováno v:
HIV medicine. 20(3)
Objectives As more HIV-positive individuals receive antiretroviral therapy (ART), payers are seeking options for covering these increased and sustained drug costs. Strategic use of available generic antiretroviral (ARV) formulations may be feasible.
Publikováno v:
HIV medicine. 19(4)
Objectives The incremental costs of expanding antiretroviral (ARV) drug treatment to all HIV-infected patients are substantial, so cost-saving initiatives are important. Our objectives were to determine the acceptability and financial impact of de-si
Autor:
Michael Gill, Hartmut B. Krentz
Publikováno v:
HIV Medicine. 16:38-47
Objectives Improved survival has shifted the HIV epidemic in the developed world towards more individuals > 50 years of age. Older individuals, with new or longstanding HIV infection, are at greater risk for HIV-related and non-HIV-related conditions
Publikováno v:
HIV Medicine. 14:293-302
Objectives Intimate partner violence (IPV) is a risk factor for HIV infection. Little is known, however, about the prevalence, clinical associations, and impact of IPV among patients living with HIV. Methods HIV-infected gay and bisexual men in South
Publikováno v:
HIV Medicine. 14:99-107
Objectives The aim of the study was to determine the risk factors predictive of symptomatic HIV-associated neurocognitive disorders (sHAND) among HIV-infected patients receiving active medical care. Methods Baseline demographic and clinical character
Publikováno v:
HIV Medicine. 10:246-252
Objective The aim of the study was to compare the performance of several bedside neuropsychological tools for detection of HIV-associated neurocognitive disorder (HAND) in antiretroviral drug-exposed persons. Methods We analysed the relative performa
Autor:
S Gingues, Michael Gill
Publikováno v:
HIV Medicine. 7:369-377
Objectives To determine the impact of highly active antiretroviral therapy (HAART) on the incidence and outcomes of Kaposi's sarcoma (KS), non-Hodgkin's lymphoma (NHL) and invasive cervical cancer/dysplasia in a well-defined geographical HIV-infected
Publikováno v:
HIV Medicine. 6:99-106
Objectives To examine changes over a 2-year period in both the mortality rate and the causes of death in a geographically defined HIV-infected population. Methods A database search of primary care information for the dates and causes of death for all
Publikováno v:
HIV Medicine. 5:93-98
To compare the direct costs of medical care in the year following HIV diagnosis for patients who present with a CD4 count200 cells/microL ('late presenters') and those who present with a CD4 count200 cells/microL ('early presenters').Direct costs (i.
Autor:
Hartmut B. Krentz, Michael Gill
Publikováno v:
HIV medicine. 9(9)
Objectives To report on the cost of medical care for HIV-infected patients stratified by CD4 cell count for a regional population over a 9-year period, and to examine the effect of reporting costs of HIV care only or only in antiretroviral therapy (A